GHK-Cu still leaves the hair question open.
Copper peptide has an interesting hair story. It also has a missing piece: the small human hair trial didn’t test GHK-Cu alone. We’ll keep that distinction in view, because it changes what the study can tell you.
The copper in the name
Three amino acids make up GHK; they’re the building blocks of protein. GHK-Cu is that chain with copper attached. The extra letters matter when we’re describing an experiment.
The human hair trial used GHK without copper. Calling its result a finding for GHK-Cu would swap one ingredient for another. Similar names don’t make them the same test.
The human study tested a mixture
We can give the study credit without giving one ingredient all the credit. Taking the second ingredient out of the explanation doesn’t take it out of the experiment.
What went on the scalp
Lee and colleagues studied men with male-pattern hair loss. Their lotion combined GHK without copper and 5-aminolevulinic acid, another ingredient. They compared it with a dummy lotion over six months.
What changed
Hair counts rose more with the mixture. Hair thickness and length didn’t differ significantly between groups. That’s a finding about the tested lotion. It doesn’t tell us how much GHK contributed or whether GHK-Cu alone would help.
Mice and lab samples tell different stories
Another study tested a GHK-Cu delivery system in mice, looking at how it reached the skin and affected hair-growth signals. It helps explain the scientific interest. It doesn’t establish a treatment for people.
A separate copper-peptide study used AHK-Cu in human hair tissue and cells outside the body. AHK-Cu is a different peptide. ‘Human’ describes where the tissue came from; it doesn’t mean people received treatment.
No reported side effects isn’t the whole safety answer
The human combination trial reported no side effects. A small study can miss uncommon harms, though, and it can’t settle long-term safety. A lotion result also can’t tell us whether an injection is safe.
FDA’s injectable GHK-Cu entry raises concerns about immune reactions linked to clumping and impurities, with little human safety information. On its page current as of April 22, 2026, the entry is ‘nominated but withdrawn’: the request to consider it was taken back. That isn’t clearance or approval. Personal hair questions belong with a licensed clinician.
Our safety and care page explains the practical differences. The papers and FDA records are on references.